

Business development is at the heart of our growth strategy; one of our main objectives is to acquire or in-license products in late-stage development or in the market. Our aim is to build strong relationships and maintain partner-of-choice status in the fields of gastroenterology and cystic fibrosis.
Over the years, we have developed a reputation as a top-tier partner in a very competitive marketplace. Our knowledge in the GI space and our high-performing sales force, in both North America and Europe, have allowed us to maximize the value of acquired and/or in-licensed products, resulting in progressively higher sales and earnings year after year.
If you would like to learn more about our guiding principles, please click here
If you are interested in learning about our deal history, please click here
If you are interested in partnering with Aptalis, please click here